Staff profile - Glenn Wadley
Dr Glenn Wadley
|Position:||Senior Lecturer |
|Faculty or Division:||Faculty of Health|
|Department:||School of Exercise and Nutrition Sciences|
|Campus:||Melbourne Burwood Campus|
|Phone:||+61 3 92446018 +61 3 92446018|
- Doctor of Philosophy, Deakin University, 2004
- Master of Applied Science, Deakin University, 2000
- Bachelor of Applied Science (Human Movement), Deakin University, 1997
- Bachelor of Education, Deakin University, 1996
- Graduate Certificate of Higher Education, Deakin University, 2012
The Australian Physiological Society
Australian Diabetes Society
Australian Society for Medical Research
American Physiological Society
School of Exercise and Nutrition Sciences, Honours Course Director
HSE303 Exercise Metabolism, Lecturer and Unit Chair
HSE201 Exercise Physiology, Lecturer
HBS400 Research Methods, Lecturer and Unit Chair
HSE401 Developing Research Skills, Lecturer and Unit Chair
HSE402/ HSN414 Honours Research Project, Lecturer and Unit Chair
Primary supervisor of Honours students, two PhD students and Co-supervisor of two PhD students
Conferences and seminars
International (* presenting author) *Strobel NA, Peake JM, Matsumoto A, Marsh SA, Coombes JS, Wadley GD. 2008. ACSM: Integrative Physiology of Exercise, East Carolina. *Wadley GD and McConell GK. 2008. Experimental Biology. San Diego. *Laker RC, Siebel AL, Wadley GD, McConell GK and Wlodek ME. 2007. 5th International Congress on Developmental Origins of Health & Disease. Perth. Ross RM, Wadley GD, Clark MG, Rattigan S and McConell GK*. 2007. American Diabetes Association, 67th Scientific Meeting, Chicago. *Wadley G. and McConell GK. 2006. American College of Sports Medicine: Integrative Physiology of Exercise. Indianapolis. *Siebel AL, Wadley GD, Leone F, Cooney G, McConell GK, Owens JA and Wlodek ME. 2006. 10th International Conference on Obesity. Sydney. *Owens JA, Leone F, Siebel AL, Wadley GD, McConell GK, Cooney G and Wlodek ME. 2006. Society for Gynecologic Investigation, Toronto. National Invited presentations Wadley GD. 2010. Do antioxidant vitamin supplements really prevent the beneficial increase in skeletal muscle mitochondrial biogenesis following exercise training? AussieMit 2010; The Garvan Institute of Medical Research, Sydney. Wadley GD. 2009. Reactive oxygen species: friends or foes? Exercise, Muscle and Metabolism Conference, Melbourne. Wadley GD. 2008. Regulation of mitochondrial biogenesis in skeletal muscle during exercise by reactive oxygen species. AussieMit Workshop New Developments in Mitochondrial Research, LaTrobe University, Melbourne.
Awards and prizes
2014: Award for Innovation in Teaching. Faculty of Health, Deakin University.
2011: Deakin University Central Research Grants Scheme Treatment of type 2 diabetes with antioxidant therapy (CIs GD Wadley, AP Russell). $25,000.
2007-2008: Heart Foundation Grant in Aid Can exercise and improved nutrition normalise myocardial mitochondrial biogenesis following growth restriction. (GD Wadley, ME Wlodek, GK McConell, J Owens). $122,887.
2007-2009: NHMRC Project Grant Can exercise and improved nutrition normalise rat skeletal muscle mitochondrial biogenesis following growth restriction. (GK McConell, ME Wlodek, GD Wadley). $325,065.
2007: The University of Melbourne Early Career Researcher Grant (0606168) Can exercise normalise mitochondrial biogenesis following fetal growth restriction? GD Wadley. $28,200.
National Heart Foundation of Australia Travel Grant 2004
National Heart Foundation of Australia Travel Grant 2000
Deakin University Postgraduate Research Scholarship 1999
Dr Wadleys research program has two major research streams centred on the impacts of physical activity and nutrition on adult health. The first stream examines the impacts of physical activity and the nutritional environments during early life on later adult health. The second research stream investigates exercise and antioxidant therapies for the treatment of type 2 diabetes and the regulation of mitochondrial biogenesis (synthesis) following exercise. Both of these topics have important implications for the treatment and prevention of type 2 diabetes and cardiovascular disease.